Michiel Lodder

Michiel Lodder

Company: 20Med Therapeutics

Job title: Chief Executive Officer


Leveraging Polymeric Nanoparticles for the Delivery of Next-Generation mRNA Vaccines & Therapeutics 1:30 pm

Examining the polymeric nanoparticle delivery platform Reviewing an innovative concept in vaccine development, thermostable vaccines Evaluating the delivery of next-generation nucleic acid vaccines and therapeuticsRead more

day: Focus Day

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.